Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05425992 · ClinicalTrials.gov registry record
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
A clinical trial of Leukemia and Non-Hodgkin Lymphoma, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05425992: Recruiting study of Leukemia and Non-Hodgkin Lymphoma, sponsored by University of Colorado, Denver.
NCT05425992 is a study of Leukemia and Non-Hodgkin Lymphoma that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 20 participants, below the 487-participant average among 233 other Leukemia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05425992, a study of Leukemia and Non-Hodgkin Lymphoma, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.
Primary Outcome
Understand the patient experience using qualitative interview of Spanish speaking patients and families Determine satisfaction based on open-ended question with unsatisfied to satisfied as markers.
Conditions Studied
Interventions
- OTHER Interview
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-17 |
| Est. Completion | 2027-12-31 |
What NCT05425992 shows while recruiting
NCT05425992 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 487-participant average among 233 other Leukemia trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT05425992 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05425992 about?
NCT05425992 is a clinical study titled "Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families". This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.
What is the current status of trial NCT05425992?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2022-03-17. Estimated completion is 2027-12-31.
What conditions does trial NCT05425992 study?
This clinical trial studies the following conditions: Leukemia, Non-Hodgkin Lymphoma.
What interventions are being tested in trial NCT05425992?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT05425992?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05425992 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05425992's enrollment target sits among peer trials
20 185th of 233 higher than 42 of 233 other Leukemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
RECRUITING · Early Phase 1
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Revumenib in Combination With 7+3 + Midostaurin in AML
RECRUITING · Phase 1
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RECRUITING · Phase 2
-
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI